Leading Consumer Health Position Hypera as a market leader in consumer health with iconic brands like Benegrip, Buscopan, Engov, Epocler, Estomazil, Neosaldina and Zero-Cal, presenting a strong opportunity to upsell OTC and vitamin products to pharmacies and clinics that stock top-selling brands.

Diversified Portfolio Leverage Hypera’s breadth across prescription, consumer health, dermocosmetics and generics to offer bundled solutions and cross-category campaigns to retailers and hospital channels, expanding trade terms and joint promotional activities.

Institutional Market Entry Hyperа has recently expanded into the institutional market targeting clinics and hospitals, creating a channel where organized procurement can be tapped for bulk orders of generics, branded generics and dermocosmetics, with potential for long-term contracts.

Sustainability Momentum With inclusion in the ESG-focused index and a sustainability-driven growth narrative, present opportunities to align with Hypera on sustainable packaging, responsible sourcing, and ESG-compliant supplier programs to win preferred vendor status.

Strategic Partnerships Recent changes in ownership and leadership dynamics suggest an openness to new strategic partnerships and investments; approach for co-development, co-branding or distribution partnerships to accelerate market reach and product launches.